SGIOF
SHIONOGI & CO LTD
$16.00
0.00%
No data for this timeframe.
Vol
SEC Reports1
Recent Activity
May 29, 2026
Event
Market Event
Original Approval — Type 1 - New Molecular Entity
Apr 8, 2026
SEC
Shionogi Inc. secured a $119.16 million contract from the Department of Health and Human Services for the late-stage dev
GOVT-CONTRACT — Impact 5/10
Apr 6, 2026
government_contract
$119M govt contract: SHIONOGI INC
Agency: Department of Health and Human Services. LATE-STAGE DEVELOPMENT, FDA MARKETING AUTHORIZATION
Analyst Ratings
3Strong Buy
5Buy
11Hold
0Sell
0Strong Sell
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 0 neutral. Avg impact: 5.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 42% buy across 19 analysts — 3 strong buy, 5 buy, 11 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $159.3B | 59.7% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $173.4B | 53.2% | — |
| Current FY 2027-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $696.1B | 79.2% | — |
| Next FY 2028-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $723.7B | 4.0% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 5 | 11 | 0 | 0 | 42% | |
| May 1, 2026 | 3 | 5 | 11 | 0 | 0 | 42% | |
| Apr 1, 2026 | 3 | 5 | 10 | 0 | 0 | 44% | |
| Mar 1, 2026 | 3 | 4 | 10 | 0 | 0 | 41% | |
| Feb 1, 2026 | 3 | 4 | 10 | 0 | 0 | 41% | |
| Jan 1, 2026 | 3 | 3 | 9 | 0 | 1 | 38% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 29, 2026
FDA
approval
Original Approval — Type 1 - New Molecular Entity
Apr 6, 2026
government_contract
$119M govt contract: SHIONOGI INC
Agency: Department of Health and Human Services. LATE-STAGE DEVELOPMENT, FDA MARKETING AUTHORIZATION, PROCUREMENT, AND STOCKPILE OF ANTIBIOTICS FOR TH